Arrowpoint Asset Management LLC boosted its stake in athenahealth, Inc. (NASDAQ:ATHN) by 149.1% during the fourth quarter, Holdings Channel reports. The fund owned 454,069 shares of the company’s stock after buying an additional 271,759 shares during the period. Arrowpoint Asset Management LLC owned about 1.15% of athenahealth worth $47,754,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ATHN. Parkside Financial Bank & Trust raised its position in athenahealth by 13.0% in the third quarter. Parkside Financial Bank & Trust now owns 811 shares of the company’s stock valued at $102,000 after buying an additional 93 shares during the last quarter. Advisors Asset Management Inc. increased its stake in athenahealth by 1.9% in the third quarter. Advisors Asset Management Inc. now owns 895 shares of the company’s stock valued at $113,000 after buying an additional 17 shares during the period. First Quadrant L P CA acquired a new stake in athenahealth during the third quarter valued at $114,000. Russell Investments Group Ltd. acquired a new stake in athenahealth during the fourth quarter valued at $118,000. Finally, Advisor Group Inc. increased its stake in athenahealth by 13.8% in the third quarter. Advisor Group Inc. now owns 982 shares of the company’s stock valued at $124,000 after buying an additional 119 shares during the period.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth, Inc. (NASDAQ:ATHN) traded up 0.10% during mid-day trading on Thursday, hitting $116.94. The company had a trading volume of 257,409 shares. athenahealth, Inc. has a 52-week low of $90.11 and a 52-week high of $143.85. The company has a market capitalization of $4.62 billion, a P/E ratio of 224.88 and a beta of 1.77. The company has a 50-day moving average price of $117.75 and a 200 day moving average price of $115.11.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, February 2nd. The company reported $0.62 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.11. The company earned $288.20 million during the quarter, compared to analysts’ expectations of $303.72 million. athenahealth had a return on equity of 6.41% and a net margin of 1.94%. The firm’s quarterly revenue was up 11.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.45 EPS. On average, analysts forecast that athenahealth, Inc. will post $2.48 EPS for the current fiscal year.

“athenahealth, Inc. (ATHN) Stake Raised by Arrowpoint Asset Management LLC” was posted by Watch List News and is owned by of Watch List News. If you are accessing this story on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be read at http://www.watchlistnews.com/athenahealth-inc-athn-stake-raised-by-arrowpoint-asset-management-llc/1121047.html.

Several research firms have recently weighed in on ATHN. KeyCorp set a $140.00 target price on athenahealth and gave the stock a “buy” rating in a research report on Monday, February 6th. Leerink Swann set a $110.00 target price on athenahealth and gave the stock a “hold” rating in a research report on Tuesday, February 7th. Piper Jaffray Companies reiterated an “outperform” rating and set a $160.00 target price (down from $162.00) on shares of athenahealth in a research report on Tuesday, February 7th. Berenberg Bank began coverage on athenahealth in a research report on Tuesday, February 7th. They set a “buy” rating and a $143.00 target price for the company. Finally, Stifel Nicolaus decreased their target price on athenahealth from $125.00 to $116.00 and set a “hold” rating for the company in a research report on Monday, February 6th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have given a buy rating to the company. athenahealth currently has a consensus rating of “Hold” and a consensus target price of $132.79.

In other news, CEO Jonathan Bush sold 8,000 shares of the stock in a transaction on Thursday, December 15th. The stock was sold at an average price of $120.00, for a total transaction of $960,000.00. Following the completion of the transaction, the chief executive officer now directly owns 312,109 shares in the company, valued at approximately $37,453,080. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director John A. Kane sold 2,875 shares of the stock in a transaction on Friday, January 27th. The stock was sold at an average price of $123.11, for a total value of $353,941.25. Following the transaction, the director now owns 8,958 shares of the company’s stock, valued at $1,102,819.38. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 19,875 shares of company stock valued at $2,345,866. Company insiders own 3.04% of the company’s stock.

athenahealth Company Profile

athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.

5 Day Chart for NASDAQ:ATHN

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.